Navigation Links
Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'
Date:1/15/2014

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer. The group reports that the addition of Bevacizumab to the existing standard of care was safe and showed promising overall results. The 2- and 3- year overall survival rates were 89.8 percent and 80.2 percent, respectively.

"Cervical cancer is a huge problem worldwide, but isn't as big a problem in the United States. So in many ways it tends to become a somewhat overlooked and under-studied disease," says Tracey Schefter, MD, investigator at the University of Colorado Cancer Center, director of the Stereotactic Body Radiation Therapy program at the University of Colorado School of Medicine, and the study's lead author.

Risk factors for cervical cancer include infection with the human papilloma virus (HPV). Screening dramatically reduces both the likelihood of developing cervical cancer and the disease's mortality rate. Combined, these two factors mean that 80 percent of the world's approximately 473,000 yearly cases of cervical cancer occur in the developing world. In the United States, cervical cancer rates have dropped 74 percent over the previous 50 years, but is still diagnosed in approximately 10,000 women per year, with 3,500 deaths due to the disease.

The current phase II clinical trial enrolled 49 eligible patients from 28 institutions in the years 2006-2009. The study previously reported that Bevacizumab was safe and well-tolerated in combination with cisplatin and radiation therapy in this population. Now the group reports on the secondary efficacy endpoints at a median follow-up time of 3.8 years.

Specifically the group evaluated the addition of 10mg/kg bevacizumab every two weeks for 3 cycles during
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. ALS patients differ on treatment choices in later phases of disease
2. Reach2HD, a Phase II study in Huntingtons disease, launched
3. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
4. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
5. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
6. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
7. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
8. Positive results from Phase 1/2 stem cell trial reported
9. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
10. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global ... the SM1120 MEMS based ultra-miniature pressure sensor designed especially ... at only 220um x 75um provides ample space for ... With industry leading in vivo drift performance of ... broad operating pressure range from 0 to 1,100 mmHg ...
(Date:3/27/2015)... Bellevue, WA (PRWEB) March 27, 2015 ... it can be hard to know where to begin. ... an experienced Seattle trucking accident attorney, offers accident victims ... financial, and legal assistance to ensure their personal injury ... eBook begins by describing the first actions that should ...
(Date:3/27/2015)... To address their number one lawn care ... year filming this video to explain the complicated dynamics between ... it's often expected to thrive in, be it in dense ... to survive. Anytime a sun-loving plant is put in the ... Many homeowners try to amend this issue by applying large ...
(Date:3/27/2015)... Since September 2014, the country singer has been traveling to ... in retirement for a period of 13 years. Many devoted ... touring, and concert events have been booking quickly in all ... for the two shows recently scheduled for May 8 and ... of discounted Garth Brooks tickets for sale. , The comeback ...
(Date:3/27/2015)... March 27, 2015 Smile Brands Inc. ... of business support services to dental groups in the ... affiliated Castle Dental office in Hendersonville, TN. ... TN 37075, this new Castle Dental office provides families ... the latest in comprehensive, quality dental care. Hendersonville marks ...
Breaking Medicine News(10 mins):Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3
... Net Income for the Fourth Quarter was $ 0.28 per share ... Slightly For the Year ... at Year End, LANCASTER, Pa., Oct. 11 Herley Industries,Inc. (Nasdaq: HRLY ) ... Net income during the fourth quarter of 2007 was $3.8 million or $.28,per share, ...
... 11 Sutter Health and an agency,that is ... state law --,and jeopardizing public health -- by ... competency validation to be working in hospitals where,the ... Nurses,Association/National Nurses Organizing Committee today. In addition ...
... two years prompts action, QUINCY, Mass., Oct. 11 ... has removed from its shelves several,select over-the-counter cold and ... years. The voluntary withdrawal follows an announcement by several,major ... and,cold medicines citing the potential misuse of these products ...
... Oct. 11 /Xinhua-PRNewswire/ -- On,October 10, 2007, Synutra ... manufacturers of dairy-based nutritional products,for infants, children and ... stating that the Company,s common stock is no ... SEC on October 5, 2007 of the,Company,s quarterly ...
... WASHINGTON, Oct. 11 Signaling increased,momentum ... New,Hampshire recently announced the launch of new ... technology. Currently, fewer than,one-in-ten physicians take advantage ... said today., "New Hampshire is the ...
... Oct. 11 The law firm of Kohn, Swift ... has been,commenced against Pall Corporation ("Pall" or the "Company") ... States District Court for the Eastern,District of New York, ... of all investors who purchased Pall securities between April,20, ...
Cached Medicine News:Health News:Herley Reports 4th Quarter and Year-End Results 2Health News:Herley Reports 4th Quarter and Year-End Results 3Health News:Herley Reports 4th Quarter and Year-End Results 4Health News:Herley Reports 4th Quarter and Year-End Results 5Health News:Herley Reports 4th Quarter and Year-End Results 6Health News:Herley Reports 4th Quarter and Year-End Results 7Health News:Herley Reports 4th Quarter and Year-End Results 8Health News:Herley Reports 4th Quarter and Year-End Results 9Health News:Herley Reports 4th Quarter and Year-End Results 10Health News:Herley Reports 4th Quarter and Year-End Results 11Health News:Sutter Violating State Safety Laws on Assuring Proper Competency Validation of Strike Staff, Say RNs 2Health News:Stop & Shop Removes Children's Cough and Cold Medicine from Store Shelves 2Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing 2Health News:Kohn, Swift & Graf, P.C. Announces Commencement of Lawsuit Against Pall Corporation-PLL 2Health News:Kohn, Swift & Graf, P.C. Announces Commencement of Lawsuit Against Pall Corporation-PLL 3
(Date:3/26/2015)... , March 26, 2015 Zimmer Holdings, ... Vivacit-E ® Advanced Bearing Technology with Vitamin ... A paper published earlier this month reported that, at ... Vivacit-E Advanced Bearing Technology featuring Vitamin E grafted ... a significant wear rate reduction of 95 percent, with ...
(Date:3/26/2015)... , Californie, 26 mars 2015 Finesse ... spécialement conçu pour les innovateurs, visionnaires et cadres ... Cette conférence d,une durée de deux jours proposée ... situé dans le centre ville de ... septembre 2015. Il s,agira d,un forum destiné aux ...
(Date:3/26/2015)...  Flexpoint Sensor Systems, Inc. (OTCBB: FLXT) today announced ... and shipped during the last 90 days. ... the sensors for gloves and medical uses. Several new ... sensors built for them. Some of these new clients ... medical rehab; a major international electronics manufacturer who is ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Finesse Solutions annonce l'événement Cellworld 2015 2Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2
... 2011  Allocate Software plc, the leading provider of workforce ... its presence in the US with the announcement that ... scheduling solution, to create and manage schedules for its ... a leading provider of a diverse range of imaging ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that ... present a corporate overview at the Bank of America Merrill ... at 7:30 a.m. ET.  The conference will be held at ... A live webcast and audio archive of the presentation will ...
Cached Medicine Technology:Allocate Software's Healthroster Selected by Austin Radiological Association 2
... ventilated microcentrifuge combines powerful, quiet performance with attractive, ... that gives you maximum value...MORE for LESS., ... to 17,000 xg at speeds of 13,500 rpm ... mL) microtubes., More Features , Microlite ...
... single rotation speed of 10,000 rpm , ... , Pellets single- and double-stranded DNA , ... , 12-position rotor holds 0.5-ml microcentrifuge tubes ... , Replaceable rotor , Safety ...
... The Centrifuge 4-15C is designed to accommodate ... provide the necessary force of more than 5600 ... wide range of both fixed-angle and swing-out rotors ... 5 ml, 15 ml, and 50 ml tubes, ...
... High performance Model 5417 C spins up to ... model offers unsurpassed safety, reliability, and ease of use. ... the lab bench or in a cold room and ... application range., Product features , Spin up ...
Medicine Products: